Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

108 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical decision-making for immunotherapy in metastatic renal cell carcinoma.
Schmidinger M. Schmidinger M. Curr Opin Urol. 2018 Jan;28(1):29-34. doi: 10.1097/MOU.0000000000000456. Curr Opin Urol. 2018. PMID: 29045250 Review.
Vinorelbine and interferon-alpha2c as second-line therapy in metastatic renal cell carcinoma.
Schmidinger M, Steger GG, Budinsky AC, Wenzel C, Brodowicz T, Locker GJ, Kramer G, Marberger M, Zielinski CC. Schmidinger M, et al. Anticancer Drugs. 2000 Mar;11(3):175-9. doi: 10.1097/00001813-200003000-00005. Anticancer Drugs. 2000. PMID: 10831276 Clinical Trial.
Sequential administration of interferon gamma and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial. Austrian Renal Cell Carcinoma Study Group.
Schmidinger M, Steger GG, Wenzel C, Locker GJ, Brodowicz T, Budinsky AC, Wiltschke C, Kramer G, Marberger M, Zielinski CC. Schmidinger M, et al. Cancer Immunol Immunother. 2000 Sep;49(7):395-400. doi: 10.1007/s002620000128. Cancer Immunol Immunother. 2000. PMID: 10999466 Clinical Trial.
Glutathione in the prevention of cisplatin induced toxicities. A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancer.
Schmidinger M, Budinsky AC, Wenzel C, Piribauer M, Brix R, Kautzky M, Oder W, Locker GJ, Zielinski CC, Steger GG. Schmidinger M, et al. Wien Klin Wochenschr. 2000 Jul 28;112(14):617-23. Wien Klin Wochenschr. 2000. PMID: 11008323 Clinical Trial.
Sequential administration of interferon-gamma, GM-CSF, and interleukin-2 in patients with metastatic renal cell carcinoma: results of a phase II trial.
Schmidinger M, Steger G, Wenzel C, Locker GJ, Budinsky AC, Brodowicz T, Kramer G, Marberger M, Zielinski CC; Austrian Renal Cell Carcinoma Study Group. Schmidinger M, et al. J Immunother. 2001 May-Jun;24(3):257-62. J Immunother. 2001. PMID: 11394504 Clinical Trial.
Sequential Administration of Interferon-gamma, GM-CSF, and Interleukin-2 in Patients With Metastatic Renal Cell Carcinoma: Results of a Phase II Trial.
Schmidinger M, Steger G, Wenzel C, Locker GJ, Budinsky AC, Brodowicz T, Kramer G, Marberger M, Zielinski CC. Schmidinger M, et al. J Immunother (1991). 2001 May;24(3):257-262. J Immunother (1991). 2001. PMID: 11395642
Capecitabine in the treatment of metastatic renal cell carcinoma failing immunotherapy.
Wenzel C, Locker GJ, Schmidinger M, Mader R, Kramer G, Marberger M, Rauchenwald M, Zielinski CC, Steger GG. Wenzel C, et al. Among authors: schmidinger m. Am J Kidney Dis. 2002 Jan;39(1):48-54. doi: 10.1053/ajkd.2002.29879. Am J Kidney Dis. 2002. PMID: 11774101 Clinical Trial.
Relapsed, poor-prognosis ovarian cancer, individualized, interdisciplinary treatment approach, and quality of life: a case report.
Wenzel CC, Schmidinger MP, Locker GJ, Jakesz R, Steger GG. Wenzel CC, et al. Among authors: schmidinger mp. Support Care Cancer. 2002 Jan;10(1):81-3. doi: 10.1007/s005200100243. Support Care Cancer. 2002. PMID: 11777194
Combined analysis of two phase II trials in patients with primary and advanced breast cancer with epidoxorubicin and docetaxel+granulocyte colony stimulating factor.
Wenzel C, Locker GJ, Schmidinger M, Rudas M, Taucher S, Gnant MF, Jakesz R, Steger GG. Wenzel C, et al. Among authors: schmidinger m. Anticancer Drugs. 2002 Jan;13(1):67-74. doi: 10.1097/00001813-200201000-00008. Anticancer Drugs. 2002. PMID: 11914643 Clinical Trial.
The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing?
Hejna M, Schmidinger M, Raderer M. Hejna M, et al. Among authors: schmidinger m. Ann Oncol. 2002 May;13(5):653-68. doi: 10.1093/annonc/mdf142. Ann Oncol. 2002. PMID: 12075733 Review.
108 results
Jump to page
Feedback